End-of-day quote
Shanghai S.E.
23:00:00 20/05/2024 BST
|
5-day change
|
1st Jan Change
|
17.37
CNY
|
-1.70%
|
|
-1.70%
|
-3.23%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
25,096
|
11,424
|
9,872
|
9,554
|
-
|
-
|
Enterprise Value (EV)
1 |
25,096
|
11,424
|
9,872
|
9,554
|
9,554
|
9,554
|
P/E ratio
|
9.67
x
|
18.7
x
|
99.7
x
|
51.1
x
|
15.6
x
|
25.9
x
|
Yield
|
0.86%
|
0.8%
|
0.31%
|
0.58%
|
1.21%
|
1.15%
|
Capitalization / Revenue
|
2.6
x
|
1.46
x
|
1.4
x
|
0.95
x
|
0.76
x
|
0.74
x
|
EV / Revenue
|
2.6
x
|
1.46
x
|
1.4
x
|
0.95
x
|
0.76
x
|
0.74
x
|
EV / EBITDA
|
7.71
x
|
9.54
x
|
19
x
|
8.13
x
|
5.77
x
|
6.04
x
|
EV / FCF
|
14,673,555
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.04
x
|
1.32
x
|
1.14
x
|
1.09
x
|
0.99
x
|
1.04
x
|
Nbr of stocks (in thousands)
|
550,000
|
550,000
|
550,000
|
550,000
|
-
|
-
|
Reference price
2 |
45.63
|
20.77
|
17.95
|
17.37
|
17.37
|
17.37
|
Announcement Date
|
21/02/22
|
01/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
9,635
|
7,798
|
7,050
|
10,028
|
12,651
|
12,833
|
EBITDA
1 |
-
|
3,255
|
1,197
|
519
|
1,175
|
1,656
|
1,581
|
EBIT
1 |
-
|
2,858
|
788.7
|
105
|
232
|
802.5
|
460
|
Operating Margin
|
-
|
29.67%
|
10.11%
|
1.49%
|
2.31%
|
6.34%
|
3.58%
|
Earnings before Tax (EBT)
1 |
-
|
2,858
|
788.3
|
104.4
|
231
|
778
|
459
|
Net income
1 |
715.1
|
2,150
|
607.8
|
98.62
|
185
|
610.5
|
367
|
Net margin
|
-
|
22.31%
|
7.79%
|
1.4%
|
1.84%
|
4.83%
|
2.86%
|
EPS
2 |
1.730
|
4.720
|
1.110
|
0.1800
|
0.3400
|
1.110
|
0.6700
|
Free Cash Flow
|
-
|
1,710
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
17.75%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
52.54%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
79.56%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.3910
|
0.1660
|
0.0550
|
0.1000
|
0.2100
|
0.2000
|
Announcement Date
|
24/08/21
|
21/02/22
|
01/03/23
|
18/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
1,710
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
47.7%
|
7.24%
|
1.14%
|
2.1%
|
6.17%
|
4%
|
ROA (Net income/ Total Assets)
|
-
|
32%
|
-
|
0.86%
|
1.4%
|
4.48%
|
2.6%
|
Assets
1 |
-
|
6,724
|
-
|
11,413
|
13,214
|
13,642
|
14,115
|
Book Value Per Share
2 |
-
|
15.00
|
15.70
|
15.70
|
15.90
|
17.50
|
16.80
|
Cash Flow per Share
2 |
-
|
5.870
|
1.970
|
1.120
|
1.690
|
2.640
|
2.210
|
Capex
1 |
-
|
965
|
3,041
|
4,383
|
1,012
|
796
|
512
|
Capex / Sales
|
-
|
10.02%
|
39%
|
62.17%
|
10.09%
|
6.29%
|
3.99%
|
Announcement Date
|
24/08/21
|
21/02/22
|
01/03/23
|
18/03/24
|
-
|
-
|
-
|
Last Close Price
17.37
CNY Average target price
17.52
CNY Spread / Average Target +0.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.23% | 1.32B | | +4.13% | 105B | | -6.35% | 62.84B | | +72.86% | 49.15B | | +15.33% | 38.45B | | +5.32% | 32.61B | | +14.73% | 20.65B | | +12.59% | 16.81B | | +18.15% | 15.14B | | +3.29% | 14.14B |
Other Commodity Chemicals
|